These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3734054)

  • 21. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2',3' cyclic nucleotide 3' phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE.
    Birnbaum G; Kotilinek L; Schlievert P; Clark HB; Trotter J; Horvath E; Gao E; Cox M; Braun PE
    J Neurosci Res; 1996 May; 44(4):381-96. PubMed ID: 8739158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The neuropathology of chronic relapsing experimental allergic encephalomyelitis induced in the Lewis rat by inoculation with whole spinal cord and treatment with cyclosporin A.
    Pender MP; Stanley GP; Yoong G; Nguyen KB
    Acta Neuropathol; 1990; 80(2):172-83. PubMed ID: 2389682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A new pattern of spinal-cord demyelination in guinea pigs with acute experimental allergic encephalomyelitis mimicking multiple sclerosis.
    Colover J
    Br J Exp Pathol; 1980 Aug; 61(4):390-400. PubMed ID: 7426390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative analysis of the cellular constituents of the cerebrospinal fluid in chronic relapsing experimental allergic encephalomyelitis.
    Suckling AJ; Baron PW; Mauer U; Burger R; Rumsby MG
    J Neuroimmunol; 1986 Mar; 11(1):57-66. PubMed ID: 3484750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.
    Bolton C; Allsopp G; Cuzner ML
    Clin Exp Immunol; 1982 Jan; 47(1):127-32. PubMed ID: 6178543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low-dose cyclosporin A induces relapsing remitting experimental allergic encephalomyelitis in the Lewis rat.
    Polman CH; Matthaei I; de Groot CJ; Koetsier JC; Sminia T; Dijkstra CD
    J Neuroimmunol; 1988 Feb; 17(3):209-16. PubMed ID: 3257496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experimental allergic encephalomyelitis in guinea pigs. Influence of thymosin fraction V on the disease.
    Woyciechowska J; Goldstein AL; Driscoll B
    J Neuroimmunol; 1985 Jan; 7(4):215-9. PubMed ID: 2578135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroimmunomodulation by allogeneic seminal vesicle fluid in CNS is sex-independent.
    Pakravan N; Ghaffarinia A; Parvaneh S; Yaslianifard S; Jalili C; Riazi-Rad F
    Neurol Res; 2016 Feb; 38(2):103-9. PubMed ID: 27118606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chronic relapsing experimental allergic encephalomyelitis. Correlation of circulating lymphocyte fluctuations with disease activity in suppressed and unsuppressed animals.
    Traugott U; Stone SH; Raine CS
    J Neurol Sci; 1979 Mar; 41(1):17-29. PubMed ID: 86602
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-T cell monoclonal antibodies in vivo. II. Modulation of acute and chronic experimental allergic encephalomyelitis (EAE) in guinea pigs.
    Sobel RA; Blanchette BW; Russo MA; Williams AM; Colvin RB
    J Immunol; 1987 Apr; 138(8):2507-13. PubMed ID: 3494072
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ellagic acid protects from myelin-associated sphingolipid loss in experimental autoimmune encephalomyelitis.
    Busto R; Serna J; Perianes-Cachero A; Quintana-Portillo R; García-Seisdedos D; Canfrán-Duque A; Paino CL; Lerma M; Casado ME; Martín-Hidalgo A; Arilla-Ferreiro E; Lasunción MA; Pastor Ó
    Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Sep; 1863(9):958-967. PubMed ID: 29793057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of pregnancy on experimental allergic encephalomyelitis in guinea pigs and rats.
    Keith AB
    J Neurol Sci; 1978 Oct; 38(3):317-26. PubMed ID: 569689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ameliorating effects of hyperbaric oxygenation on experimental allergic encephalomyelitis.
    Prockop LD; Grasso RJ
    Brain Res Bull; 1978; 3(3):221-5. PubMed ID: 709384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic relapsing experimental allergic encephalomyelitis: effect of age at the time of sensitization on clinical course and pathology.
    Lassmann H; Wisniewski HM
    Acta Neuropathol; 1979 Jul; 47(2):111-6. PubMed ID: 474071
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Blood-brain barrier and DNA changes during the evolution of experimental allergic encephalomyelitis.
    Oldendorf WH; Towner HF
    J Neuropathol Exp Neurol; 1974 Oct; 33(5):616-31. PubMed ID: 4436687
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibition of blood-brain barrier disruption in experimental allergic encephalomyelitis by short-term therapy with dexamethasone or cyclosporin A.
    Paul C; Bolton C
    Int J Immunopharmacol; 1995 Jun; 17(6):497-503. PubMed ID: 7499026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oligoclonal IgG bands in the cerebrospinal fluid of monkeys with experimental allergic encephalomyelitis.
    Chu A; Leon M; Nerurkar L; Iivanainen M; Namba M; London W; Madden D; Sever J
    Prog Clin Biol Res; 1984; 146():347-52. PubMed ID: 6326160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Demonstration of serum IgG antibodies against myelin during the course of relapsing experimental allergic encephalomyelitis in guinea pigs.
    Olsson T; Kristensson K; Leijon G; Link H
    J Neurol Sci; 1982 Jun; 54(3):359-75. PubMed ID: 7097308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunosuppressive effect of cyclosporin A in two lymphocyte transfer models in rats: comparison of in vivo and in vitro treatment.
    Ryffel B; Feurer C; Heuberger B; Borel JF
    Immunobiology; 1982 Dec; 163(5):470-83. PubMed ID: 6984418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relation between the increase in the diffusional permeability of the blood-central nervous system barrier and other changes during the development of experimental allergic encephalomyelitis in the Lewis rat.
    Daniel PM; Lam DK; Pratt OE
    J Neurol Sci; 1983; 60(3):367-76. PubMed ID: 6415240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.